Technical Analysis for TNXP - Tonix Pharmaceuticals Holding Corp.

Grade Last Price % Change Price Change
D 1.04 -4.59% -0.05
TNXP closed down 4.59 percent on Thursday, April 15, 2021, on 31 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical TNXP trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -4.59%
Wide Bands Range Expansion -4.59%
Oversold Stochastic Weakness -4.59%
Stochastic Buy Signal Bullish -4.59%
Wide Bands Range Expansion -4.59%
Oversold Stochastic Weakness -4.59%
Wide Bands Range Expansion -4.59%
Older End-of-Day Signals for TNXP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lower Bollinger Band Support about 18 hours ago
Down 5% about 19 hours ago
Down 3% about 20 hours ago
60 Minute Opening Range Breakdown about 21 hours ago
Outside Day about 21 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company's lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Pharmaceutical Products Health Sciences Disorders Stage Specialty Pharmaceutical Headache Fibromyalgia Headaches Post Traumatic Stress Disorder Seth Lederman

Is TNXP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.46
52 Week Low 0.51
Average Volume 31,894,625
200-Day Moving Average 0.93
50-Day Moving Average 1.30
20-Day Moving Average 1.23
10-Day Moving Average 1.14
Average True Range 0.11
ADX 14.46
+DI 15.59
-DI 26.40
Chandelier Exit (Long, 3 ATRs ) 1.25
Chandelier Exit (Short, 3 ATRs ) 1.35
Upper Bollinger Band 1.47
Lower Bollinger Band 1.00
Percent B (%b) 0.09
BandWidth 38.19
MACD Line -0.05
MACD Signal Line -0.03
MACD Histogram -0.0234
Fundamentals Value
Market Cap 162.85 Million
Num Shares 157 Million
EPS -8.25
Price-to-Earnings (P/E) Ratio -0.13
Price-to-Sales 0.00
Price-to-Book 1.53
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.22
Resistance 3 (R3) 1.23 1.18 1.19
Resistance 2 (R2) 1.18 1.13 1.18 1.18
Resistance 1 (R1) 1.11 1.11 1.09 1.10 1.17
Pivot Point 1.06 1.06 1.05 1.06 1.06
Support 1 (S1) 0.99 1.01 0.97 0.98 0.91
Support 2 (S2) 0.94 0.99 0.94 0.90
Support 3 (S3) 0.87 0.94 0.89
Support 4 (S4) 0.86